Skip to main content

1 Result(s)

within Li-Qiang Pan Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin

    Utilization of antibodies to deliver highly potent cytotoxic agents to corresponding antigen-overexpressed tumor cells is a clinically validated therapeutic strategy. Ofatumumab (OFA, trade name Arzerra) is a ...

    Zhao Hui Li, Qian Zhang, Hai Bin Wang, Ya Nan Zhang, Ding Ding… in Investigational New Drugs (2014)